Four months into the job, CEO James Peterson looks to advance the company’s legacy through in-house genetic development and leveraging the “food as medicine” trend. Keep reading
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.